No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 22, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal

by TheAdviserMagazine
3 weeks ago
in Business
Reading Time: 2 mins read
A A
89bio, Inc. (ETNB) Shareholders to Receive Up to .5B Total in Roche Buyout Deal
Share on FacebookShare on TwitterShare on LInkedIn


We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. 89bio, Inc. is one of them.

89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardiometabolic diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH). Its lead candidate, pegozafermin, is a long-acting FGF21 analog designed to treat moderate to severe MASH, including advanced fibrosis, as well as related metabolic disorders.

In September 2025, Roche announced a definitive agreement to acquire 89bio, Inc. (NASDAQ:ETNB) for $14.50 per share in cash, valuing the company at approximately $2.4 billion. Shareholders will also receive a non-tradeable contingent value right (CVR) potentially worth up to $6 per share based on pegozafermin’s commercial success, bringing the total deal value to roughly $3.5 billion. This acquisition reflects strong confidence in pegozafermin’s potential as a best-in-class therapy for MASH, a serious liver condition often associated with obesity, and positions ETNB among the best performing stocks in the biotech sector.

89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal

Roche plans to integrate pegozafermin into its cardiovascular, renal, and metabolic portfolio, leveraging global development, manufacturing, and commercialization capabilities to maximize the therapy’s impact. The transaction is expected to close in Q4 2025 following unanimous board approval from both companies.

While we acknowledge the potential of ETNB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.



Source link

Tags: 3.5b89biobuyoutdealETNBReceiveRocheshareholdersTotal
ShareTweetShare
Previous Post

Sector hits back at Labour’s international fee levy

Next Post

Millions of 401(k)s Are Left Behind, and It’s Costing Workers

Related Posts

edit post
YXT regains compliance with Nasdaq’s minimum bid price requirement (YXT:NASDAQ)

YXT regains compliance with Nasdaq’s minimum bid price requirement (YXT:NASDAQ)

by TheAdviserMagazine
October 22, 2025
0

YXT.com Group Holding Ltd. (NASDAQ: NASDAQ:YXT) said on Wednesday it has regained compliance with Nasdaq’s minimum bid price requirement after...

edit post
As national debt accelerates to  trillion, watchdog warns it’s ‘no way for a great nation like America to run its finances’

As national debt accelerates to $38 trillion, watchdog warns it’s ‘no way for a great nation like America to run its finances’

by TheAdviserMagazine
October 22, 2025
0

The U.S. national debt has surged past $38 trillion, according to the U.S. Treasury Department, just two months after surpassing...

edit post
Pegasystems signals accelerating Pega Cloud momentum with ACV growth and partner-driven AI innovation (NASDAQ:PEGA)

Pegasystems signals accelerating Pega Cloud momentum with ACV growth and partner-driven AI innovation (NASDAQ:PEGA)

by TheAdviserMagazine
October 22, 2025
0

Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...

edit post
Netflix’s blockbuster run loses spark amid valuation jitters

Netflix’s blockbuster run loses spark amid valuation jitters

by TheAdviserMagazine
October 22, 2025
0

Netflix shares fell more than 10% on Wednesday, as the streaming giant's outlook for the coming quarter left investors nonplussed...

edit post
Corning CEO says Jeff Bezos taught him that creating value is less about overcoming failure than, ‘if something is working, double down on it’

Corning CEO says Jeff Bezos taught him that creating value is less about overcoming failure than, ‘if something is working, double down on it’

by TheAdviserMagazine
October 22, 2025
0

On this episode of Fortune’s Leadership Next podcast, cohosts Diane Brady, executive editorial director of the Fortune CEO Initiative and Fortune Live...

edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

by TheAdviserMagazine
October 22, 2025
0

Travel booking company Navan, formerly TripActions, will reportedly hold its IPO on Nasdaq next week at a company valuation...

Next Post
edit post
Millions of 401(k)s Are Left Behind, and It’s Costing Workers

Millions of 401(k)s Are Left Behind, and It’s Costing Workers

edit post
Crypto.com Granted Full Set of CFTC Derivatives Licenses for U.S. Expansion

Crypto.com Granted Full Set of CFTC Derivatives Licenses for U.S. Expansion

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Tesla (TSLA) Q3 adj. earnings drop despite higher revenues

Tesla (TSLA) Q3 adj. earnings drop despite higher revenues

0
edit post
Sugar Prices Retreat to Multi-Year Lows on the Outlook for Ample Global Supplies

Sugar Prices Retreat to Multi-Year Lows on the Outlook for Ample Global Supplies

0
edit post
Virtual Staging Tech is So Good Now That It’s Earning Flippers and Investors More Money

Virtual Staging Tech is So Good Now That It’s Earning Flippers and Investors More Money

0
edit post
New Rothbard Letters Show His Early Opposition to both Nixon and Reagan

New Rothbard Letters Show His Early Opposition to both Nixon and Reagan

0
edit post
XRP Derivatives Expand on Bybit—Futures and Options Fuel Market Momentum

XRP Derivatives Expand on Bybit—Futures and Options Fuel Market Momentum

0
edit post
Financial infidelity hurts, but there are ways to get past it

Financial infidelity hurts, but there are ways to get past it

0
edit post
XRP Derivatives Expand on Bybit—Futures and Options Fuel Market Momentum

XRP Derivatives Expand on Bybit—Futures and Options Fuel Market Momentum

October 22, 2025
edit post
Shutdown hits breakaway advisors starting RIAs

Shutdown hits breakaway advisors starting RIAs

October 22, 2025
edit post
YXT regains compliance with Nasdaq’s minimum bid price requirement (YXT:NASDAQ)

YXT regains compliance with Nasdaq’s minimum bid price requirement (YXT:NASDAQ)

October 22, 2025
edit post
Tesla (TSLA) Q3 adj. earnings drop despite higher revenues

Tesla (TSLA) Q3 adj. earnings drop despite higher revenues

October 22, 2025
edit post
As national debt accelerates to  trillion, watchdog warns it’s ‘no way for a great nation like America to run its finances’

As national debt accelerates to $38 trillion, watchdog warns it’s ‘no way for a great nation like America to run its finances’

October 22, 2025
edit post
Willow Processor Maps Molecules 13,000x Faster Than Supercomputer: Google

Willow Processor Maps Molecules 13,000x Faster Than Supercomputer: Google

October 22, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • XRP Derivatives Expand on Bybit—Futures and Options Fuel Market Momentum
  • Shutdown hits breakaway advisors starting RIAs
  • YXT regains compliance with Nasdaq’s minimum bid price requirement (YXT:NASDAQ)
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.